GUGGENHEIM CAPITAL LLC - ALDER BIOPHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$245,000
-80.5%
19,973
-81.8%
0.00%
-66.7%
Q2 2017$1,255,000
-36.3%
109,556
+15.7%
0.00%
-40.0%
Q1 2017$1,970,000
+5.2%
94,725
+5.3%
0.01%0.0%
Q4 2016$1,872,000
-30.8%
89,980
+9.1%
0.01%
-37.5%
Q3 2016$2,704,000
+19.4%
82,508
-9.1%
0.01%
+14.3%
Q2 2016$2,265,000
-15.9%
90,718
-17.5%
0.01%
-12.5%
Q1 2016$2,693,000
+42.6%
109,971
+92.3%
0.01%
+60.0%
Q4 2015$1,889,000
+12.7%
57,187
+11.8%
0.01%0.0%
Q3 2015$1,676,00051,1590.01%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Novo Holdings A/S 3,201,183$40,591,0003.96%
Cormorant Asset Management, LP 150,000$1,902,0000.39%
PFM Health Sciences, LP 1,034,030$13,112,0000.30%
Partner Investment Management, L.P. 23,660$300,0000.11%
PointState Capital LP 375,000$4,755,0000.09%
Spark Investment Management LLC 38,400$486,0000.07%
SECTORAL ASSET MANAGEMENT INC 89,300$1,132,0000.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 95,722$1,214,0000.05%
CADIAN CAPITAL MANAGEMENT, LP 120,000$1,522,0000.04%
Nicholas Investment Partners, LP 49,341$626,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders